Since Pirfenidone is metabolised with the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is probably going to precipitate the toxicity of pirfenidone: concomitant therapy should be to be avoided. 8 An interaction involving host and environmental factors causes repetitive microinjuries of alveolar epithelial cells, simultaneous activation of multiple https://terryg443rcn6.shoutmyblog.com/29232438/the-basic-principles-of-adavosertib